Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cells|January 9, 2026
Advances in Targeting Growth Factor Signalling in Neuroblastoma and Overcoming Drug ResistanceKarina Ivanenko, Ruslan Shaymardanov, Vladimir Prassolov, et al.
Cells|September 23, 2022
Emetine in Combination with Chloroquine Induces Oncolytic Potential of HIV-1-Based Lentiviral ParticlesPavel Spirin, Elena Shyrokova, Valeria Vedernikova, et al.
Cells|March 12, 2025
Systematic Comparison of FBS and Medium Variation Effect on Key Cellular Processes Using Morphological ProfilingTimofey Lebedev, Alesya Mikheeva, Valentina Gasca, et al.
International Journal of Molecular Sciences|November 11, 2022
MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK DownregulationNikolay Bondarev, Karina Ivanenko, Elmira Khabusheva, et al.
Cells|March 29, 2023
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic PerspectiveTimofey Lebedev, Rubina Kousar, Bbumba Patrick, et al.
International Journal of Molecular Sciences|July 27, 2022
Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival SignalingTimofey Lebedev, Anton Buzdin, Elmira Khabusheva, et al.
Biomedicines|December 24, 2021
Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer DrugsElmira Vagapova, Maxim Kozlov, Timofey Lebedev, et al.
Oncotarget|September 17, 2017
Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitorsPavel Spirin, Timofey Lebedev, Natalia Orlova, et al.
Pageof 3